Purpose: To describe a patient with Thygeson's superficial punctate keratitis successfully treated with long-term cyclosporin A.
Case Presentation: A 15-year-old boy presented with long-term ocular symptoms of foreign body sensation, burning, irritation, tearing, and transient photophobia. One year's treatment with steroidal agents had led to only partial improvement. Clinical and laboratory evaluation yielded a diagnosis of Thygeson's superficial punctate keratitis. Treatment with 0.5% topical cyclosporin A for the last 4.5 years has been associated with symptom resolution and corneal clearing, without side effects.
Conclusion: Topical cyclosporin A seems to effective and safe for the treatment of Thygeson's superficial punctuate keratitis and should be considered in selective cases when topical steroids fail or in there is a high risk of complications from long-term steroid treatment. Considering the chronicity of Thygeson's superficial punctate keratitis, further prospective studies of long-term cyclosporine A treatment are needed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636787 | PMC |
| http://dx.doi.org/10.1186/1757-1626-1-415 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rare Case of Thygeson Superficial Punctate Keratitis After COVID-19 Vaccination.
Cornea
October 2023
Faculty of Medicine and Health Sciences, Department of Ophthalmology and Visual Sciences, McGill University, Montreal, QC, Canada; and.
Purpose: The aim of this study was to elucidate a rare corneal association of the coronavirus disease 2019 (COVID-19) vaccine. Although cases of corneal involvement after vaccination have been reported, we present the first case of Thygeson superficial punctate keratitis (TSPK) linked to the COVID-19 vaccine.
Methods: This study is a case report.
Thygeson's superficial punctate keratitis in children.
Eye (Lond)
November 2023
UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Objective: To describe the first paediatric case series of Thygesons' superficial punctate keratitis (TSPK) with management outcomes.
Methods: A retrospective chart review was done for all children either diagnosed at initial presentation or referred with TSPK from 01/2012 to 08/2021 at a tertiary children's hospital. Records were assessed for signs, symptoms, diagnosis, steroid and cyclosporine 0.
[Modern possibilities of pathogenetically oriented therapy for dry eye syndrome].
Vestn Oftalmol
April 2023
Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia.
In recent years, anti-inflammatory therapy has become a significant part of the complex approach to treatment of patients with dry eye syndrome (DES), with cyclosporine preparations becoming increasingly important in the structure of the therapy. Taking into account the immunosuppressive effect of cyclosporine A, which is realized through hindering the activation of T-lymphocytes in the tissues of the ocular surface, its topical application in DES has a pronounced pathogenetic focus. Numerous clinical studies have shown that instillations of cyclosporine into the conjunctival cavity contribute to an increase in total tear production, as well as recovery of the density of goblet cells in the conjunctiva of DES patients.
View Article and Find Full Text PDFBilateral Thygeson's Superficial Punctate Keratitis with Dendritic Corneal Lesion: A Case Report.
Medicina (Kaunas)
January 2023
Department of Ophthalmology, Kyung Hee University College of Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
Thygeson's superficial punctate keratitis (TSPK) is a recurrent bilateral corneal epithelial disease. Typically, small, multiple discrete epithelial lesions occur in the central cornea. However, dendritic corneal lesions are rare.
View Article and Find Full Text PDFChronic bilateral multifocal superficial keratitis in a pediatric patient.
Am J Ophthalmol Case Rep
June 2022
Byers Eye Institute, Department of Ophthalmology, Stanford University, Stanford, CA, United States.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!